NGS Group AB (publ) provides recruitment and staffing services in the healthcare, school, social services, and finance areas in Sweden, Norway, and Finland. More Details
Undervalued with excellent balance sheet.
Share Price & News
How has NGS Group's share price performed over time and what events caused price changes?
Latest Share Price and Events
Stable Share Price: NGS is less volatile than 75% of Swedish stocks over the past 3 months, typically moving +/- 4% a week.
Volatility Over Time: NGS's weekly volatility (4%) has been stable over the past year.
7 Day Return
1 Year Return
Return vs Industry: NGS underperformed the Swedish Healthcare industry which returned 22.4% over the past year.
Return vs Market: NGS underperformed the Swedish Market which returned 13.3% over the past year.
Long-Term Price Volatility Vs. Market
How volatile is NGS Group's share price compared to the market and industry in the last 5 years?
Simply Wall St News
2 weeks ago | Simply Wall StHow Many NGS Group AB (publ) (STO:NGS) Shares Have Insiders Sold, In The Last Year?
1 month ago | Simply Wall StNGS Group (STO:NGS) Has A Pretty Healthy Balance Sheet
2 months ago | Simply Wall StHere's What We Learned About The CEO Pay At NGS Group AB (publ) (STO:NGS)
Is NGS Group undervalued compared to its fair value and its price relative to the market?
Undervalued compared to fair value
Share Price vs. Fair Value
Below Fair Value: NGS (SEK14.85) is trading below our estimate of fair value (SEK28.23)
Significantly Below Fair Value: NGS is trading below fair value by more than 20%.
Price To Earnings Ratio
PE vs Industry: NGS is good value based on its PE Ratio (16.4x) compared to the SE Healthcare industry average (21.9x).
PE vs Market: NGS is good value based on its PE Ratio (16.4x) compared to the Swedish market (23.6x).
Price to Earnings Growth Ratio
PEG Ratio: Insufficient data to calculate NGS's PEG Ratio to determine if it is good value.
Price to Book Ratio
PB vs Industry: NGS is good value based on its PB Ratio (0.6x) compared to the SE Healthcare industry average (1.6x).
How is NGS Group forecast to perform in the next 1 to 3 years based on estimates from 0 analysts?
Forecasted Healthcare industry annual growth in earnings
In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as NGS Group has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.
This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.
- Examine whether NGS Group is trading at an attractive price based on how much it is expected to earn in the future, and relative to its industry peers and the wider market.
- NGS Group competitive advantages and company strategy can generally be found in its financial reports archived here.
- Explore growth companies in the Healthcare industry.
How has NGS Group performed over the past 5 years?
Historical annual earnings growth
Earnings and Revenue History
Quality Earnings: NGS has high quality earnings.
Growing Profit Margin: NGS's current net profit margins (1.8%) are lower than last year (3.3%).
Past Earnings Growth Analysis
Earnings Trend: NGS's earnings have declined by 15.4% per year over the past 5 years.
Accelerating Growth: NGS's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.
Earnings vs Industry: NGS had negative earnings growth (-56.8%) over the past year, making it difficult to compare to the Healthcare industry average (-11.1%).
Return on Equity
High ROE: NGS's Return on Equity (3.6%) is considered low.
How is NGS Group's financial position?
Financial Position Analysis
Short Term Liabilities: NGS's short term assets (SEK87.5M) exceed its short term liabilities (SEK83.6M).
Long Term Liabilities: NGS's short term assets (SEK87.5M) exceed its long term liabilities (SEK6.0M).
Debt to Equity History and Analysis
Debt Level: NGS's debt to equity ratio (8.8%) is considered satisfactory.
Reducing Debt: Insufficient data to determine if NGS's debt to equity ratio has reduced over the past 5 years.
Debt Coverage: NGS's debt is well covered by operating cash flow (88.1%).
Interest Coverage: NGS's interest payments on its debt are well covered by EBIT (6.6x coverage).
What is NGS Group current dividend yield, its reliability and sustainability?
Dividend Yield vs Market
Notable Dividend: Unable to evaluate NGS's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.
High Dividend: Unable to evaluate NGS's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.
Stability and Growth of Payments
Stable Dividend: Insufficient data to determine if NGS's dividends per share have been stable in the past.
Growing Dividend: Insufficient data to determine if NGS's dividend payments have been increasing.
Current Payout to Shareholders
Dividend Coverage: NGS is not paying a notable dividend for the Swedish market.
Future Payout to Shareholders
Future Dividend Coverage: No need to calculate the sustainability of NGS's dividend in 3 years as they are not forecast to pay a notable one for the Swedish market.
How experienced are the management team and are they aligned to shareholders interests?
Average board tenure
Ingrid Nordlund (52 yo)
Ms. Ingrid Nordlund has been the Chief Executive Officer of NGS Group AB (publ) since 2008. Ms. Nordlund is a Director of Transcendent Group AB (publ) since 2018. Ms. Nordlund serves as the Chairman of the...
CEO Compensation Analysis
Compensation vs Market: Ingrid's total compensation ($USD420.37K) is above average for companies of similar size in the Swedish market ($USD239.45K).
Compensation vs Earnings: Ingrid's compensation has been consistent with company performance over the past year.
|Independent Director||5yrs||kr125.00k||0.44% |
|Independent Director||1.67yrs||kr50.00k||0.033% |
|Director||3yrs||no data||2.4% |
|Independent Chairman of the Board||1.67yrs||kr225.00k||0.022% |
Experienced Board: NGS's board of directors are not considered experienced ( 2.3 years average tenure), which suggests a new board.
Who are the major shareholders and have insiders been buying or selling?
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Recent Insider Transactions
Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.
NGS Group AB (publ)'s company bio, employee growth, exchange listings and data sources
- Name: NGS Group AB (publ)
- Ticker: NGS
- Exchange: OM
- Industry: Health Care Services
- Sector: Healthcare
- Market Cap: kr133.990m
- Shares outstanding: 9.02m
- Website: https://www.ngsgroup.se
Number of Employees
- NGS Group AB (publ)
- Kungsgatan 12
- Stockholm County
- 111 35
|Ticker||Exchange||Primary Security||Security Type||Country||Currency||Listed on|
|NGS||OM (OMX Nordic Exchange Stockholm)||Yes||Common Shares||SE||SEK||Feb 2007|
|0RPC||LSE (London Stock Exchange)||Yes||Common Shares||GB||SEK||Feb 2007|
NGS Group AB (publ) provides recruitment and staffing services in the healthcare, school, social services, and finance areas in Sweden, Norway, and Finland. The company is based in Stockholm, Sweden.
Company Analysis and Financial Data Status
|Data||Last Updated (UTC time)|
|Company Analysis||2021/01/16 19:19|
|End of Day Share Price||2021/01/15 00:00|
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.